Another great find montanus regarding Ponezumab. Pfizer must have or nearly complete their Phase II data for Ponezumab via ILNS. It would be great to get an trial data PR on this and Shire for their Phase I trial for FA as well.
I was just talking about this and something else this past Thursday night along with other issues.
Heck Pfizer may very well push the next phase faster then Shire is going but it will be close.
I was told from someone before the restructure was inked the early summer of 2014 that the company was going to be broke up and sold off like a car being sold for parts.
Wonder if Elliot has any advanced talks with Pfizer regarding a sale of Ponezumab cause it is sure covered under the license agreement imho.
Then sell SHP-622 to Shire and take the high bidder regarding TauC3 seems like a good finish plus the milestone coming later this summer from Shire.
Maybe that will get us back past a dime lol cause this pps don't make any sense cause that file folder has some very important agreements.
News 
Market Data 
Discover 
